Clinical application of transarterial chemoembolization combined with terminal branches portal vein embolization in planned hepatectomy

Guoqing Zhu; Wenhao Hu; Wei Xiang; Junwei Ni; Liyang Dong

doi:10.53730/ijhs.v7n3.14563

Authors

Guoqing Zhu
zhuguoqing2007@wzhospital.cn
Wenzhou Medical University, Wenzhou, China
Wenhao Hu Wenzhou Medical University, Wenzhou, China
Wei Xiang Wenzhou Medical University, Wenzhou, China
Junwei Ni Wenzhou Medical University, Wenzhou, China
Liyang Dong Wenzhou Medical University, Wenzhou, China

Keywords:

hepatocellular carcinoma, transarterial chemoembolization, terminal branches portal vein embolization, hepatectomy

Abstract

This study aimed to investigate the clinical efficacy of transarterial chemoembolization (TACE) in conjunction with terminal branches portal vein embolization (TBPVE) in the context of planned hepatectomy. A cohort of five patients afflicted by primary hepatocellular carcinoma who were deemed unsuitable candidates for primary surgical resection was gathered from August 2019 to December 2021. Following the application of TACE in combination with TBPVE as a therapeutic intervention, we observed postoperative general reactions, alterations in tumor biomarkers, hyperplasia of future liver remnant (FLR), and subsequent surgical resection. All patients successfully underwent the combined TACE and TBPVE procedure, achieving a technical success rate of 100%. One week after TACE, alpha-fetoprotein (AFP) levels decreased from 38.52±49.21 to 25.27±37.94 μg/L, and Protein Induced by Vitamin K Absence or Antagonist (PIVKA) levels decreased from 1689.30±1663.83 to 219.03±228.10 μg/L. Two weeks post-TBPVE, FLR exhibited an increment from 350.80±41.17 to 476.00±57.91 mL. The ratio of FLR to standard liver volume (SLV) increased from 30.94%±3.63% to 42.03%±5.62%. The combined application of TACE and TBPVE not only effectively manages tumor progression but also augments the FLR, thereby affording patients with a limited future liver remnant an opportunity for surgical resection of hepatocellular carcinoma.

Downloads

Download data is not yet available.

References

Abulkhir, A., Limongelli, P., Healey, A. J., Damrah, O., Tait, P., Jackson, J., ... & Jiao, L. R. (2008). Preoperative portal vein embolization for major liver resection: a meta-analysis. Annals of surgery, 247(1), 49-57.

Adam, R., Laurent, A., Azoulay, D., Castaing, D., & Bismuth, H. (2000). Two-stage hepatectomy: a planned strategy to treat irresectable liver tumors. Annals of surgery, 232(6), 777.

Alvarez, F. A., Castaing, D., Figueroa, R., Allard, M. A., Golse, N., Pittau, G., ... & Vibert, E. (2018). Natural history of portal vein embolization before liver resection: a 23-year analysis of intention-to-treat results. Surgery, 163(6), 1257-1263.

Aoki, T., & Kubota, K. (2016). Preoperative portal vein embolization for hepatocellular carcinoma: consensus and controversy. World journal of hepatology, 8(9), 439.

Azoulay, D., Castaing, D., Smail, A., Adam, R., Cailliez, V., Laurent, A., ... & Bismuth, H. (2000). Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Annals of surgery, 231(4), 480.

Baili, E., Tsilimigras, D. I., Filippou, D., Ioannidis, A., Bakopoulos, A., Machairas, N., ... & Moris, D. (2019). Associating liver partition and portal vein ligation for staged hepatectomy in patients with primary liver malignancies: A systematic review of the literature. Group, 18, 19.

Brouquet, A., Abdalla, E., Kopetz, S., Garrett, C., Overman, M., Eng, C., ... & Vauthey, J. N. (2011). High Survival Rate After Two-Stage Resection of Advanced Colorectal Liver Metastases.

Glantzounis, G. K., Tokidis, E., Basourakos, S. P., Ntzani, E. E., Lianos, G. D., & Pentheroudakis, G. (2017). The role of portal vein embolization in the surgical management of primary hepatobiliary cancers. A systematic review. European Journal of Surgical Oncology (EJSO), 43(1), 32-41. https://doi.org/10.1016/j.ejso.2016.05.026

Imamura, H., Seyama, Y., Makuuchi, M., & Kokudo, N. (2008, June). Sequential transcatheter arterial chemoembolization and portal vein embolization for hepatocellular carcinoma: the university of Tokyo experience. In Seminars in interventional radiology (Vol. 25, No. 02, pp. 146-154). © Thieme Medical

Kothary, N., Weintraub, J. L., Susman, J., & Rundback, J. H. (2007). Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk. Journal of Vascular and Interventional Radiology, 18(12), 1517-1526. https://doi.org/10.1016/j.jvir.2007.07.035

Lesurtel, M., Müllhaupt, B., Pestalozzi, B. C., Pfammatter, T., & Clavien, P. A. (2006). Transarterial chemoembolization as a bridge to liver transplantation for hepatocellular carcinoma: an evidence-based analysis. American Journal of Transplantation, 6(11), 2644-2650. https://doi.org/10.1111/j.1600-6143.2006.01509.x

Llovet, J. M., & Beaugrand, M. (2003). Hepatocellular carcinoma: present status and future prospects. Journal of hepatology, 38, 136-149. https://doi.org/10.1016/S0168-8278(02)00432-4

Makuuchi, M., Thai, B. L., Takayasu, K., Takayama, T., Kosuge, T., Gunven, P., ... & Ozaki, H. (1990). Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery, 107(5), 521-527.

Menon, K. V., Al-Mukhtar, A., Aldouri, A., Prasad, R. K., Lodge, P. A., & Toogood, G. J. (2006). Outcomes after major hepatectomy in elderly patients. Journal of the American college of Surgeons, 203(5), 677-683. https://doi.org/10.1016/j.jamcollsurg.2006.07.025

Moris, D., Ronnekleiv-Kelly, S., Kostakis, I. D., Tsilimigras, D. I., Beal, E. W., Papalampros, A., ... & Pawlik, T. M. (2018). Operative results and oncologic outcomes of associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) versus two-stage hepatectomy (TSH) in patients with unresectable colorectal liver metastases: a systematic review and meta-analysis. World journal of surgery, 42, 806-815.

Moris, D., Ronnekleiv-Kelly, S., Rahnemai-Azar, A. A., Felekouras, E., Dillhoff, M., Schmidt, C., & Pawlik, T. M. (2017). Parenchymal-sparing versus anatomic liver resection for colorectal liver metastases: a systematic review. Journal of Gastrointestinal Surgery, 21, 1076-1085.

Pandanaboyana, S., Bell, R., Hidalgo, E., Toogood, G., Prasad, K. R., Bartlett, A., & Lodge, J. P. (2015). A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection. Surgery, 157(4), 690-698. https://doi.org/10.1016/j.surg.2014.12.009

Pastell, H., Tuomainen, P., Virkki, L., & Tenkanen, M. (2008). Step-wise enzymatic preparation and structural characterization of singly and doubly substituted arabinoxylo-oligosaccharides with non-reducing end terminal branches. Carbohydrate Research, 343(18), 3049-3057. https://doi.org/10.1016/j.carres.2008.09.013

Peng, S. Y., Huang, C. Y., Li, J. T., Zhang, Y. Y., He, X. W., Wang, Y. F., ... & Cai, X. J. (2016). Terminal branches portal vein embolization for planed hepatectomy. Zhonghua wai ke za zhi [Chinese Journal of Surgery], 54(9), 664-668.

Peng, S. Y., Huang, C. Y., Wang, X. A., Zhang, Y. Y., Wang, J. W., Xu, B., ... & Cai, X. J. (2021). The clinical value of terminal branches portal vein embolization for hepatocellular carcinoma with insufficient future liver remnant. Zhonghua wai ke za zhi [Chinese Journal of Surgery], 59(10), 829-835.

Reddy, S. K., Barbas, A. S., Turley, R. S., Steel, J. L., Tsung, A., Marsh, J. W., ... & Clary, B. M. (2011). A standard definition of major hepatectomy: resection of four or more liver segments. Hpb, 13(7), 494-502. https://doi.org/10.1111/j.1477-2574.2011.00330.x

Schelotto, P. B., & Gondolesi, G. (2017). Laparoscopy in ALPPS procedure: when we can do it?. Annals of surgery, 265(4), e30-e31.

Schnitzbauer, A. A., Lang, S. A., Goessmann, H., Nadalin, S., Baumgart, J., Farkas, S. A., ... & Schlitt, H. J. (2012). Right portal vein ligation combined with in situ splitting induces rapid left lateral liver lobe hypertrophy enabling 2-staged extended right hepatic resection in small-for-size settings. Annals of surgery, 255(3), 405-414.

Shindoh, J., Tzeng, C. W. D., Aloia, T. A., Curley, S. A., Huang, S. Y., Mahvash, A., ... & Vauthey, J. N. (2014). Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. Journal of Gastrointestinal Surgery, 18, 45-51.

Song, T. J., Ip, E. W. K., & Fong, Y. (2004). Hepatocellular carcinoma: current surgical management. Gastroenterology, 127(5), S248-S260. https://doi.org/10.1053/j.gastro.2004.09.039

Thanassi, D. G., Saulino, E. T., & Hultgren, S. J. (1998). The chaperone/usher pathway: a major terminal branch of the general secretory pathway. Current opinion in microbiology, 1(2), 223-231. https://doi.org/10.1016/S1369-5274(98)80015-5

Van Lienden, K. P., Van Den Esschert, J. W., De Graaf, W., Bipat, S., Lameris, J. S., Van Gulik, T. M., & Van Delden, O. M. (2013). Portal vein embolization before liver resection: a systematic review. Cardiovascular and interventional radiology, 36, 25-34.

Wakabayashi, H., Ishimura, K., Izuishi, K., Karasawa, Y., & Maeta, H. (2004). Evaluation of liver function for hepatic resection for hepatocellular carcinoma in the liver with damaged parenchyma. Journal of Surgical Research, 116(2), 248-252.

Yamashita, S., Sakamoto, Y., Yamamoto, S., Takemura, N., Omichi, K., Shinkawa, H., ... & Kokudo, N. (2017). Efficacy of preoperative portal vein embolization among patients with hepatocellular carcinoma, biliary tract cancer, and colorectal liver metastases: a comparative study based on single-center experience of 319 cases. Annals of surgical oncology, 24, 1557-1568.